Article
REG4 independently predicts better prognosis in non-mucinous colorectal cancer.
PloS one - 1 Jan 2014
Kaprio Tuomas, Hagström Jaana, Mustonen Harri, Koskensalo Selja, Andersson Leif C, Haglund Caj
Abstract excerpt
INTRODUCTION: Colorectal cancer (CRC) is one of the world's three most common cancers and its incidence is rising. To identify patients who benefit from adjuvant therapy requires novel biomarkers. The regenerating islet-derived gene (REG) 4 belongs to a group of small secretory proteins involved in cell proliferation and regeneration. Its up-regulated expression occurs in inflammatory bowel diseases also in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
